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Imaging of Clival Hypoplasia in CHARGE Syndrome and
Hypothesis for Development: A Case-Control Study
X C.M. de Geus, X J.E.H. Bergman, X C.M.A. van Ravenswaaij-Arts, and X L.C. Meiners
ABSTRACT
BACKGROUND AND PURPOSE: We present the largest case series to date on basiocciput abnormalities in CHARGE syndrome
(Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth and/or development, Genital and/or urinary
abnormalities, and Ear abnormalities and/or deafness). We aimed to show that basiocciput abnormalities are common and may aid in
diagnosis. We furthermore explored whether clivus size correlates with the type of chromodomain-helicase-DNA binding protein 7 gene
(CHD7) mutation, which causes CHARGE syndrome, and with clinical criteria according to Blake et al and Verloes.
MATERIALS ANDMETHODS: We retrospectively analyzed the clivus of 23 patients with CHARGE syndromewithCHD7mutations onMR
imaging or CT. We recorded the size of the clivus, the Welcher angle, basilar invagination, and Chiari I malformations. We compared the
clival size and Welcher angle of patients with CHARGE syndrome with those of 72 age-matched controls. Additionally, we tested for
correlations between clivus size and mutation type or clinical criteria.
RESULTS: Eighty-seven percent of the patients with CHARGE syndrome had an abnormal clivus; 61% had a clivus2.5 SD smaller than that of
age-matchedcontrols.Anabnormally largeWelcheranglewasobserved in35%.Basiocciputhypoplasiawas found in70%,andbasilar invagination,
in 29%. None of the patients had a Chiari I malformation. At the group level, patients with CHARGE syndrome had a smaller clivus and larger
Welcher angle than controls. No signiﬁcant correlation between clivus size and mutation type or clinical criteria was found.
CONCLUSIONS: Most patients with CHARGE syndrome have an abnormal clivus. This suggests that clivus abnormalities may be used as
an additional diagnostic tool. Our results provide evidence that CHD7,which is expressed in the presomitic mesoderm during somitogen-
esis, plays an important role in the formation of the clivus.
ABBREVIATIONS: Ba-Xs exosphenobasion; Ba-Es endosphenobasion; CHARGE Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of
growth and/or development, Genital and/or urinary abnormalities, and Ear abnormalities and deafness; CHD7 chromodomain-helicase-DNA binding protein 7 gene.
The animal homologue is Chd7. Non-italicized CHD7 (human) and Chd7 (animal) refer to the protein.
Coloboma of the eye, Heart defects, Atresia of the choanae,Retardation of growth and/or development, Genital and/or uri-
nary abnormalities, and Ear abnormalities and deafness (CHARGE)
syndrome is a complex disorder withmultiple congenital anomalies
that occurs in approximately 6 in 100,000 live births.1 First de-
scribed independently by Hall2 and Hittner et al3 in 1979, the
acronym CHARGE was coined by Pagon et al in 1981.4 Many
more features are associated with the syndrome, such as semicir-
cular canal dysplasia, facial nerve palsy, anosmia with or without
olfactory bulb hypoplasia, delayed puberty, and cleft lip/palate.
Clinical criteria have been published by Blake et al5 in 1998, Ver-
loes6 in 2005, and Hale et al7 in 2015, which aid in the clinical
diagnosis (On-line Table 1). Guidelines for cranial imaging were
published by de Geus et al8 in 2017. In 2004, CHARGE syndrome
was found to be caused by mutations or deletions of the chro-
modomain-helicase-DNA binding protein 7 gene (CHD7) gene,
and molecular confirmation currently plays a pivotal role in the
diagnosis.9 Pathogenicmutations in theCHD7 gene usually occur
de novo, though familial occurrence has been described.10
There is greatphenotypicdiversity inCHARGEsyndrome,which
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complicates early diagnosis. CT and MR imaging in CHARGE may
play an important role in the diagnosis by demonstrating congenital
abnormalities of the labyrinth, which are present in almost all pa-
tients and can be assessed on CT andMR imaging.11 Olfactory bulb
hypoplasia, cerebellar dysplasia, and other congenital brain abnor-
malities may be demonstrated on MR imaging, but they are not in-
variably present in all patients.12,13 Morphologic changes of the cli-
vus in CHARGE syndromewere first described on neuroimaging by
Fujita et al in 2009.14 A smaller size, a malformed shape, platybasia,
basilar invagination, andChiari Imalformations have since been de-
scribed by several authors.15-18 Normally, the body of the sphenoid
occupies the upper portion of the clivus and is joined to the basilar
occipital bone to form the complete clivus (Fig 1A).19 Steepness (of
the clivus) may be quantified by the Welcher angle formed by a line
through the frontal skull base and a line along thedorsal clivus (Fig 2A).
In the present study, we have elaborated on the previously
published basiocciput findings by evaluating a large cohort of
patientswithmolecularly provedCHARGE syndrome in compar-
ison with age-matched controls. We further attempted to corre-
late clival size with mutation type and clinical criteria.
MATERIALS AND METHODS
Patients
The diagnosis of CHARGE syndrome was molecularly confirmed
in all patients. CHD7 nonsense and frameshift mutations and
larger deletions were categorized as truncating (ie, mutations
leading to a nonfunctional protein or no protein at all). CHD7
missense mutations were categorized as nontruncating (ie, muta-
tions leading to production of an altered protein that may have
residual function).CHD7 splice site mutationsmay have truncat-
ing or nontruncating effects, and these mutations could therefore
not be further categorized. All patients were scored using the
Blake et al5 and Verloes6 criteria (On-line Table 1).
Neuroimaging was performed in the authors’ hospital in 12 pa-
tients on a 1.5T scanner (Siemens, Erlangen, Germany) using a reg-
ular head coil. The remainder of the patients were scanned at other
hospitals using different scanners (1–1.5T) of different brands using
different protocols. Only patients with sagittal T1 2D TSE, 3D T1
MPRAGE, or a sagittal 2D T2 TSE imaging were included in this
study. Three patients assessed at an external hospital had a CT scan
with the possibility of sagittal reconstruction of a transverse CT scan
of either a head scan or a mastoid scan.
All neuroimaging studies were assessed and measurements
were made by an experienced pediatric neuroradiologist
(L.C.M.).
Controls
Age-matched controls from 6 age groups (0–3months and 1, 2, 6,
10, and 16 years of age) had been scanned for various neurologic
and endocrine indications, not suspicious for CHARGE syn-
FIG 1. Clival abnormalities in CHARGE syndrome. A, Sagittal T1 scan of a 4.5-year-old boy without CHARGE syndrome.White lines show the
measurement of the Ba-Es and Ba-Xs. B, A 22-month-old boy with CHARGE syndrome (patient 14). He has a hypoplastic sclerotome of the clivus
(arrow) with a large Welcher angle. Although the top of the odontoid process of the dens does not extend cranially to the Chamberlain line,
there is a slight angulation of the medulla oblongata without impression. C andD, Clival size versus age.White dots show length of the Ba-Es (C)
and Ba-Xs (D) of the individual controls; black dots show the same parameters of individual patients with CHARGE syndrome.
FIG 2. Platybasia in patients with CHARGE syndrome.A, Sagittal T1 scan of a 4.5-year-old boywithout CHARGE syndrome. TheWelcher line is shown
inwhite. B, A 22-month-old boywith CHARGE syndrome (patient 14). Note the largeWelcher angle on themidsagittal T1 scan.C,Welcher angle versus
age.White dots show theWelcher angle of the individual controls. Black dots show theWelcher angles of individual patients with CHARGE syndrome.
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drome or skull base abnormalities, on a 1.5T MR imaging sys-
tem (Siemens, Erlangen, Germany), in the authors’ hospital
between 2002 and 2014. All controls had sagittal 2D or 3D
T1-weighted MR imaging included in the scanning protocol.
The brain scan findings had been assessed as normal by various
experienced neuroradiologists, and at selection, this assess-
ment was confirmed by an experienced pediatric neuroradi-
ologist (L.C.M.).
Radiologic Analysis of the Clivus
Anatomic definitions and measurements of the clivus were used
as described by Fujita et al.14 Clivus sizewas quantified bymeasuring
the exosphenobasion (Ba-Xs) and endosphenobasion (Ba-Es, Fig
1A). This was done by measuring from the basion, the point of the
clivus at the midpoint on the anterior margin of the foramen mag-
num, to the ventral (Ba-Xs) anddorsal (Ba-Es)margins of the visible
synchondrosis.14 The Welcher angle is formed by the intersection
between the nasion-tuberculum line and the tuberculum-basion
line.20 Basioccipital hypoplasia has been defined as hypoplasia of1
of the 5 clival segments (sclerotomes) of the clivus (simplified from
Fujita et al14). Basilar invagination is commonly defined as cranial
displacement of 5 mm of the tip of the odontoid above to the
Chamberlain line. This line extends from the posteriormargin of the
foramen magnum anteriorly along the hard palate. Type I Chiari
malformation is defined as herniation of at least 1 cerebellar tonsil
5mm below the foramenmagnum.
The exosphenobasion, the endosphenobasion, the Welcher
angle, basilar invagination, and type I Chiari malformation were
measured.
Statistical Analysis
The scans of the patients with CHARGE syndrome were com-
pared with the findings on sagittal T1-weighted MR images of
72 controls in 6 age groups: 0 –3 months and 1, 2, 6, 10, and 16
years of age.
Measurements of Ba-Es, Ba-Xs, andWelcher angle in controls
were used to calculate age-specific mean and SD values. Patient
measurements were compared with age-specific mean control
values. A clivus was determined to be abnormally small if it was
2.5 SDs below its age-specific control. The Welcher angle was
determined to be abnormally large if it was 2.5 SDs above its
age-dependent control value.
Because the Ba-Es, Ba-Xs, and the Welcher angle were highly
correlated (On-line Table 2), we orthogonalized the data with
factor analysis. The first factor was then modeled with nonlinear
regression on the normal data. To control for bias due to the
difference in age distribution of patients with CHARGE syn-
drome and controls, we computed the observed minus the pre-
dicted values, which were then tested with a 2-sample t test (for
additional statistical methods, see the On-line Appendix). A
2-sided Fisher exact test was performed to examine correla-
tions between the size of the clivus and the type of mutation
(truncating versus nontruncating), the presence of choanal
atresia or coloboma, and satisfaction of the criteria of Verloes6
or Blake et al5 (listed in On-line Table 1). No t test was per-
formed for the criteria of Hale et al7 because all patients satis-
fied these criteria.
RESULTS
In total, 23 patientswith an age range of 3 days to 16 years (median
age, 20 months) were included in this study. Table 1 summarizes
the patients’ clinical criteria according to Blake et al, Verloes, and
Hale et al and their type ofCHD7mutation. The full spectrumwas
represented in patients with both clinically typical and atypical
CHARGE syndrome.
Figure 1C, -D summarizes the lengths of the Ba-Es and Ba-Xs
for patients and controls with increasing age. For 2 patients, the
presence of basilar invagination could not be reliably determined
(patients 13 and 20 in On-line Table 3). Most patients with
CHARGE syndrome (87%, 20/23) had a clivus that was small or
had abnormalmorphology or both. Fourteen patients had a clivus
of 2.5 SDs smaller than in their age-matched controls (61%,
14/23). In 8 patients (35%, 8/23), an extra synchondrosis was
seen. Just more than two-thirds (70%, 16/23) of the patients with
CHARGE syndrome showed very short clivi with loss of the nor-
mal triangular shape (basiocciput hypoplasia), which was further
illustrated by 9 of themhaving aWelcher angle of2.5 SDs above
that in controls, indicating platybasia (39%, 9/23; Fig 2C). The
Welcher angle varied between 124° and 176° (mean 140°, SD
11.2°).
The results for the comparison at the group level are shown in
On-line Tables 2 and 4 and the On-line Figure. Most of the pa-
tients with CHARGE syndrome showed a reduced value in factor
1. Factor 1 had a positive correlation with the Ba-Es and Ba-Xs
and a negative correlation with the Welcher angle. Despite some
patients with CHARGE syndrome having clearly normal values,
as a group they had significantly lower values (P  6  106),
which correspond with a smaller Ba-Es and Ba-Xs and larger
Welcher angles.
Six (29%, 6/21, missing data n  2) patients with CHARGE
syndrome showed basilar invagination. In 2 of these patients, a
minor impression of the craniovertebral junction on the medulla
Table 1: Characteristics for 23 patients with CHARGE syndrome in
our case series
Characteristics
Median age (range) 20 Mo (3 days to 16 yr)
Males 15
Females 8
Criteria of Blake et al5 satisﬁeda
Typical CHARGE syndrome 12
Negative 8
Missing data 3
Criteria of Verloes6 satisﬁeda
Typical CHARGE syndrome 12
Partial CHARGE syndrome 0
Atypical CHARGE syndrome 5
Negative 0
Missing data 6
Criteria of Hale et al7 criteria satisﬁeda 23






a See On-line Table 1.
b Truncating mutations (nonsense or frameshift) lead to a decrease in CHD7 protein.
Nontruncating (missense) mutations lead to production of an altered CHD7 protein,
which may have residual function. Splice site mutations may have truncating or
nontruncating effects.
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oblongata was suggested (see Fig 1B for an example). None of the
patients exhibited herniation of the cerebellar tonsils.
Table 2 shows the correlation among clivus size, clinical crite-
ria, and type of mutation. No significant correlation was found
between the size of the clivus in the patients with CHARGE syn-
drome and the mutation type (truncating versus nontruncating),
occurrence of facial clefts, ocular coloboma, atresia of the cho-
anae, or satisfaction of the Verloes or Blake et al criteria.
DISCUSSION
In this study, the presence of clival abnormalities was assessed in a
large group of patients with CHARGE syndrome and compared
with that in healthy controls.
Clival abnormalities in CHARGE syndrome have been pub-
lished previously. Fujita et al14 were the first to publish examples
of basioccipital hypoplasia in 7/8 patients (88%) and associated
basilar invagination in 5 (63%). Furthermore, one of their pa-
tients exhibited a Chiari I malformation and syringomyelia. Na-
tung et al15 described a case with a short clivus, fused cervical
vertebrae, occipitalization of the atlas, and basilar invagination.
Hoch et al16 found skull base hypoplasia in 9/10 and a dorsally
angulated clivus in 7/10 patients. Mahdi and Whitehead17,18 de-
scribed a child with a coronal clival cleft in 2017 and recently
published a study consisting of 15 genetically and clinically con-
firmed CHARGE cases, in which they reported a coronal cleft in
13 (87%) patients and clival hypoplasia without a cleft in the
remaining 2 patients.
Although we did not particularly assess the coronal cleft, the
prevalence of clival abnormalities and/or skull base hypoplasia in
these articles is similar to our numbers. We found that 20/23
patients with CHARGE syndrome (87%) had an abnormal clivus,
either in morphology or size. At the group level, patients with
CHARGE syndromehad a smaller clivus and largerWelcher angle
(On-line Figure). However, only 14/23 (61%) had an abnormally
small clivus, defined as 2.5 SDs smaller than that of age-
matched controls (On-line Table 3 and Fig 1). Basilar invagina-
tion was seen in only 6 patients (29%, 6/21, missing data in 2
patients), with only 2 of these patients showing aminimal impres-
sion on the ventral medulla oblongata. None of the patients in the
present study had a Chiari I malformation. If we combined our
study and the above-mentioned 2 case series, 51 of 56 patients
with CHARGE syndrome (91%) had clival abnormalities and/or
skull base hypoplasia, underscoring the potential of this feature as
a diagnostic tool in CHARGE syndrome.
However, because all of these case series represent nonran-
domly selected samples, there is a danger of overestimation. All
samples may be biased toward the more severe end of the clinical
spectrum because more severely affected patients may be more
likely to undergo cerebral imaging. Our data do not show corre-
lation between the severity of the disorder (satisfaction of clinical
criteria) and the presence of clival abnormalities. In fact, in our
case series, a large number of patients were atypical on the Verloes
criteria (5/17) or negative on the Blake et al criteria (8/20), yet
clival abnormalities were found inmost. This finding underscores
the importance of clival abnormalities on imaging in supporting
the diagnosis, especially in mildly affected patients.
Basilar invagination in patients with CHARGE syndromemay
be of clinical importance because it may cause compression of the
medulla with ensuing clinical symptoms. No obvious neurologic
symptoms that could be attributed to the basilar invagination
were reported in the clinical data of the 2 patients who showed
possible involvement of the medulla (patients 14 and 15 in On-
line Table 3). Only 1 of the patients in the series of Fujita et al14
had neurologic sequelae, but she was reported to have syringomy-
elia in addition to basilar impression.
In our study, hypoplasia of the clivus was suggested as an all-
or-nothing event: If hypoplasia was present, the degree of hyp-
oplasia was severe (Ba-Es of4 to10 SDs smaller than in con-
trols, Fig 1 and On-line Table 3). The high variability and
incomplete penetrance of specific features are well-known aspects
of CHARGE syndrome.21 CHARGE syndrome is exclusively
caused by mutations in CHD7. The chromodomain helicase
DNA-binding protein 7 (protein CHD7)9 is essential in embryo-
logic development, andmutations inCHD7 result in a wide range
of features with incomplete penetrance. Much of the clinical vari-
ability is still unexplained, though there is some correlation be-
tween clinical severity and mutation type: Patients with a mis-
sense CHD7 mutation generally have a milder presentation of
clinical features.22 In our cohort, no correlations were found
between clivus length and mutation type, satisfaction of all
CHARGE criteria, or specific symptoms. Milder missense muta-
tions are, however, fairly rare in CHARGE syndrome. This is re-
flected in our study because only 2/23 patients had a missense
mutation.
The precise function of the CHD7 protein in the formation of











 5 12 .12
 2 0
Presence of choanal atresia








 3 2 .61
 6 11
Verloes6 criteria satisﬁedc
 4 8 1.00
 2 3
Blake et al5 criteria satisﬁedc
 3 5 1.00
 4 8
Note:— indicates yes;, no.
a Four patients had a splice site mutation and could not be classiﬁed as either trun-
cating or nontruncating.
b For 1 patient, no data regarding presence of coloboma were available. For 1 patient,
no information regarding cleft lip/palate was available.
c See also On-line Table 1.
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the skull base is unknown. CHD7 is expressed in the presomitic
mesoderm during somitogenesis,23 in which it plays a role in con-
trolling left-right symmetry. Somitogenesis is an important pro-
cess in the formation of the clivus, which is formed from 4 occip-
ital somites through a complicated process. In this process, fusion
of the first 3 somites creates the rostral basiocciput.24 After for-
mation of a transient sclerotome called the proatlas, parts of the
fourth somite then form the basion. Chd7 knockdown zebrafish
exhibit irregularly shaped vertebrae,23,25 supporting the role of
CHD7 in somitogenesis. The altered anatomy of the clivus in
many patients with CHARGE syndrome may therefore reflect er-
rors in somitogenesis due to faulty CHD7 signaling.
This study has several limitations. It was based on retrospec-
tive assessment ofMR imaging and CT scans obtained at different
hospitals using different scanning protocols and image parame-
ters. Nevertheless, a sagittal MR imaging scan or a sagittal CT
reconstruction, on which the clivus could be assessed, was always
available. However, in 2 cases, the clivus was difficult to assess. An
altered anatomy of the remainder of the skull base, also described
by Natung et al,15 made the definition of clival borders difficult in
several cases. Extreme clival hypoplasia also limited accurate
measurements.
CONCLUSIONS
This is the largest case-control series on clivus abnormalities in
CHARGE syndrome, to our knowledge. Although the clinical rel-
evance of clival hypoplasia and platybasia in CHARGE syndrome
is not yet clear, the results of this study confirm the suggestion by
Mahdi andWhitehead18 that besides thewell-known labyrinthine
anomalies and hypo- or aplasia of the olfactory bulb,26 clival ab-
normalitiesmay provide an important extra clue for the diagnosis
of CHARGE syndrome in neuroimaging studies. We hypothesize
that CHD7 may play an important role in the development of
clival hypoplasia.
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